Prezent Vivo examines the limits of AI in scientific communication at Articulate 2026
October 19, 2026Artificial intelligence is becoming increasingly common across the life sciences industry, but turning adoption into measurable business value remains a challenge. For pharmaceutical and biotechnology companies, the difficulty extends beyond.
- 0
- 33 views